Summary:
Meridien Research is conducting a research study to assess the effects of an investigational oral medication for individuals with diagnosed multiple sclerosis.
Qualified participants will receive at no cost:
- Evaluations, physical exams, routine lab work
- Investigational drug or placebo
Compensation for time and travel may be available. No medical insurance is necessary.
If you are between 18 and 55 years of age and have multiple sclerosis and have suffered a relapse in the past year, you may be eligible to participate.